Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Molecular Mechanisms of Zinc Absorption in Health, Acrodermatitis Enteropathica and Celiac Disease

Hugh James Freeman

Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada

Abstract: Zinc is an essential trace element involved in a multitude of human biological processes. Normally, zinc homeostasis is largely maintained by uptake of zinc into the enterocyte involving the brush border membrane followed by baso-lateral membrane exit into the circulation. This is accomplished by distinct gene-based protein carriers (eg., ZIP4, ZnT-1) to balance zinc loss, particularly from the intestinal and urinary tracts as well as integument. A genetically-based autosomal recessive disorder, acrodermatitis enteropathica, and other disorders leading to secondary malabsorption of zinc, such as celiac disease, may alter this balance, lead to significant dermatologic and intestinal histological effects, but may be entirely reversible with oral zinc supplements. Importantly, zinc may also attenuate transglutaminase activities and has been suggested to have the potential, hypothetically, to promote the generation of “celiac-safe” products.

Keywords: zinc, ZIP4 microvillus membrane transporter, ZnT-1 basolateral membrane transporter, enterocyte zinc homeostasis, acrodermatitis entero pathica, zinc absorption and malabsorption

Received July 22, 2022; Revised August 24, 2022; Accepted September 05, 2022

Citation: Hugh James Freeman, Molecular Mechanisms of Zinc Absorption in Health, Acrodermatitis Enteropathica and Celiac Disease. International Journal of Celiac Disease, 10 (1). 8-10. January 2022. doi:10.12691/ijcd-10-1-6

1. Introduction

Zinc is an essential trace element that plays a critical role in several human biological processes as one of the most abundant micronutrients in the human body, after iron [1,2]. Most zinc is present in bone and skeletal muscle, estimated to total about 2.6 g. Each day, zinc from the diet and endogenous zinc from secretions in the intestinal lumen, become available for uptake to compensate for zinc losses through different tissue sites so as to maintain zinc homeostasis [3,4]. Human in vivo studies on the mechanisms involved in zinc uptake are limited and dated [5,6]. As a result, much recent information on intestinal transport and absorption of zinc has been derived from from in vitro model systems, including experimental animals, tissues, cells (often from cultured conditions, eg. Caco-2) and isolated membrane vesicle preparations in the laboratory. Details of these studies have been reviewed by others elsewhere [7]. Zinc is associated with more than 2800 proteins, required for catalytic, structural and regulatory functions, gene expression, metalloenzyme activities, cell processes including differentiation, apoptosis and proliferation as well as signalling, especially with immune function and neural modulation [7].

2. Human Zinc Homeostasis and Deficiency

In healthy individuals, plasma or serum zinc levels range from 12 to 16 uM. Less than 1% of total body zinc is mainly bound to albumin, macro- globulin and transferrin with only nano-molar concentrations of free zinc rapidly exchangeable between different tissues. Still, since most zinc is found in bone and skeletal muscle, turnover and availability between different compartments is slow. As a result, zinc requirements must be continuously replenished largely from dietary sources with losses from fecal and urinary excretions, sweat, menstrual losses, hair, nails and desquamated skin. Added physiological requirements occur with pregnancy, lactation and early infancy (7). Zinc homeostasis is largely maintained by intestinal uptake in the small intestine over a broad range of dietary intakes. With deficiency states, usual fecal and urinary losses are reduced and, eventually plasma zinc falls, followed by losses from less exchangeable sites including bone and muscle. Zinc deficiency is usually associated with limited food supply, especially with reduced bioavailability (eg., vegetarians, elderly and with impaired absorption, as in celiac disease). Because of the lack of a suitable biomarker for zinc deficiency, mildly deficient states may be difficult to clinically recognize even though the consequences to health may be severe. Once recognized, symptoms may be entirely reversible, solely with zinc supplementation.

3. Intestinal Absorption and the Epithelial Cell

Zinc may be absorbed along the length of the entire small intestine, but, in humans, the major sites appear to be proximal in the duodenum and jejunum [5,6]. At the apical or microvillus brush border membrane of the enterocyte, zinc uptake occurs followed by excretion at the baso-lateral membrane into the portal blood with binding primarily to circulating albumin for distribution to the body. With usual dietary intake, kinetic evaluation of zinc absorption suggests a carrier-mediated and saturable process, although at high luminal zinc concentrations, uptake may be by passive diffusion. At the brush border membrane, absorption occurs through ZIP4 protein (zinc-ligand binding protein) encoded by the gene SLC39A4 on chromosome 8q24.3. This protein transports zinc from the lumen of the small intestine into the epithelial cell. An autosomal recessive mutation in this gene leads to impaired zinc absorption [8,9]. ZnT-1 is a basolateral membrane protein that transports zinc from the enterocyte to the portal blood. Other transporters have been described (ZIP 5 and ZIP 14) that also import zinc from blood into enterocytes or bi-directionally between the lumen and the epithelial cell, possibly providing an added regulatory mechanism for zinc homeostasis [10,11]. Within the enterocyte, zinc is present in 3 principal pools that may be regulated to maintain cellular zinc homeostasis: bound to protein (particularly metallothionein-bound zinc serving as a buffering compartment), free zinc stored in vesicles or as free cytoplasmic zinc with these latter 2 pools believed to be the biologically active forms of the zinc ion [7].

4. Acrodermatitis Enteropathica

This is a genetically-based zinc skin disease usually seen in infants due to differing gene mutations for the gene encoding ZIP4 with resulting impaired zinc absorption from the small intestine [8,9]. A hereditary form was also described in a 33-yr old female with minimal diarrhea, but clinically responsive to oral zinc [12] The prevalence of the disorder has been estimated at 1 to 9 in 1,000,000 with a global incidence rate of 1in 500,000 newborns [13,14]. Clinical features appear after human breast-fed infants, rich in zinc, are weaned. In addition, a zinc-binding ligand in human breast milk, absent or diminished in other animal milk, increases the bioavailability of zinc, especially in the first 1 to 2 months of lactation. Early on, the skin lesion shows a decrease in the granular layer with confluent parakeratosis, but with aging, ballooning degeneration and necrosis of keratinocytes is described reflected in sharply demarcated, dry, scaly and erythematous plaques, often in the peri-oral and genital areas. Hair and nail changes may also occur, including diffuse alopecia. Systemic changes include diarrhea, irritability, lethargy, growth retardation, anemia, neuro-psychiatric changes, hypogonadism, eye and immunological changes [13,14].

Plasma zinc levels less than 65 ug per L may assist in confirming the diagnosis but zinc levels are influenced by contamination of collection tubes, time of day, co-existent inflammatory disorders and low serum albumin. Skin biopsies are not believed to be diagnostic. Other disorders may cause mimicry, including differing malabsorption syndromes, including celiac disease. Treatment involves zinc supplementation with an anticipated response of 100%. If not treated, the disorder may be fatal or associated with significant morbidities including dermatitis, alopecia, growth retardation and serious bacterial and fungal infections. With zinc, hypocupremia has been described in adults and so monitoring of serum copper (along with zinc) has been recommended [13,14]. Interestingly, reversible small intestinal mucosal biopsy changes were described by some [15,16], but not all [17,18] investigators with zinc therapy. Patchy inflammatory changes of variable severity with mild to moderate architectural changes in the small intestine were believed to be due to zinc deficiency in acrodermatitis enteropathica [15]. For 3 infants (2 males and 1 female, aged 4 to 9 months) changes were completely reversible with each patient showing an initial partial response to di-iodohyroxy-quinoline, followed by complete small intestinal histological response to oral zinc [16]. In a separate report, investigators described apparently normal small intestinal mucosal biopsies, but ultrastructural changes in Paneth cells, possibly secondary to zinc deficiency rather than as a primary defect [19].

5. Malabsorption and Celiac Disease

In adults, similar changes have been described in patients with malabsorption syndromes, including skin changes, impaired zinc uptake and deficiency [20,21], particularly in children with newly diagnosed celiac disease complicated by severe malnutrition [20]. A similar study evaluated zinc homeostasis in children relative to severity of biopsy changes (Marsh 3 or more). Although there was no change in the fractional absorption of zinc and calculated gut function, the exchangeable zinc pool was lower in celiac children with severe histological changes [22]. Interestingly, a zinc absorption test after oral zinc sulphate administration was described to evaluate small intestinal function in celiac disease and associated small intestinal mucosal disease in dermatitis herpetiformis to evaluate gluten-free diet compliance [23]. Zinc supplementation in children with celiac disease complicated with short stature and diarrhea was also compared to zinc deficient children on a gluten-free diet [24]. Plasma zinc levels increased with a gluten-free diet regardless of use of zinc supplements. In addition [25], children with newly diagnosed celiac disease and treated with a gluten-free diet were evaluated for levels of zinc, copper and iron. One of 2 groups also received zinc supplements, but there were no significant differences detected suggesting that a gluten-free diet alone was sufficient. These findings also support recent observations [26] that iron supplements are not necessary in adults with newly diagnosed celiac disease permitting treatment of the anemia solely with a gluten-free diet. Thus, most studies in celiac disease and secondary malabsorption have been reported in children Further evaluations in adult celiac disease are needed.

6. Summary and Conclusions

Zinc absorption in human small intestine is transport-mediated with uptake into the bloodstream through brush border (eg., ZIP4) and baso-lateral (eg., ZnT-1) membrane protein carriers that are genetically-based to maintain normal zinc homeostasis. Acrodermatitis enteropathica is an autosomal recessive membrane transport protein disorder that may lead to severe clinical findings associated with zinc deficiency. Usually, the disorder appears in early infancy after weaning from human breast milk, however, adults with the disorder have been reported. Early recognition and treatment with oral zinc appears to be sufficient to reverse clinical changes in children including microscopic and ultrastructural changes in the small intestinal mucosa. Similar changes may develop in patients with malabsorption, including superimposed clinical and histopathological changes in celiac disease. In addition, however, recent information [27] suggests that zinc is a key regulator of transglutaminase activity.

Zinc may modulate transglutaminase activity (specifically, TG 2) in celiac disease [27]. Zinc is known to inhibit transglutaminase activities and, possibly, play a very critical role in celiac disease [28], dermatitis herpetiformis (with epidermal TG 3) and attenuation of transglutaminase (TG 2) activity [29]. Indeed, zinc could, conceivably, produce celiac-safe products [30]. Added studies are needed to further explore this potentially exciting role of zinc in celiac disease.

References

[1]   | King JC. Zinc: an essential bu elusive nutrient. Am J Clin Nutr 2011; 94: 6795-6845.
[2]   | Maret W. Zinc in cellular regulation. The nature and significance of “zinc signals”. Int J Mol Sci 2017; 18: 2285.
[3]   | Krebs NF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 2000; 130: 1374S-1377S.
[4]   | Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF. Zinc bioavailability and homeostasis. Am J Clin Nutr 2010; 91: 1478S-1483S.
[5]   | Steinhardt HJ, Alibi SA. Interaction between transport of zinc and other solutes in human intestine. Am J Physiol 1984; 247: G176-G182.
[6]   | Lee HH, Prasad AS, Brewer GJ, Owyang C. Zinc absorption in human small intestine. Am J Physiol 1989; 256: G87-G91.
[7]   | Maares M, Haase H. A guide to human zinc absorption: general overview and recent advances of in vitro intestinal models. Nutrients 2020; 12: 762.
[8]   | Kury S, Dreno B, Bezieau S, Giraudet S, Kharfi M, Kamoun R, Moisan JP. Identification of slc39a4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002; 31: 239-240.
[9]   | Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002; 71: 66-73.
[10]   | Wang F, Kim BE, Petris MJ, Eide DJ. The mammalian zip5 protein is a zinc transporter that localizes to the basolateral surface of polarized cells. J Biol Chem 2004; 279: 51433-51441.
[11]   | Guthrie GJ, Aydemir TB, Troche C, Martin AB, Chang SM, Cousins RJ. Influence of zip14 (slc39a14) on intestinal zinc processing and barrier function. Am J Physiol Gastrointest Liver Physiol 2015; 308: G171-G1778.
[12]   | Graves K, Kestenbaum T, Kalivas J. Hereditary acrodermatitis enteropathica in an adult. Arch Dermatol 1980; 116: 562-564.
[13]   | Ogawa Y, Kinoshita M, Shimada S, Kawamura T. Zinc and skin disorders. Nutrients 2018; 10.
[14]   | Ciampo IR, Sawamura R, Ciampo LA, Fernandes MI. Acrodermatitis enteropathica: clinical manifestations and pediatric diagnosis. Rev Paul Pediatr 2018; 36: 238-241.
[15]   | Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal Pathology and its Clinical Implications Volume II. Igaku-Shoin, Tokyo. 1992; 778.
[16]   | Kelly R, Davidson GP, Townley RR, Campbell PE. Reversible intestinal mucosal abnormality in acrodermatitis enteropathica. Arch Dis Child 1976; 51: 219-222.
[17]   | Neldner KH, Hagler L, Wise WR, Stifel FB, Lufkin EG, Herman RH. Acrodermatitis enteropathica. Arch Dermatol 1974; 110:711.
[18]   | Ament ME, Broviac J. Acrodermatitis enteropathica: demonstration of small and large intestinal mucosal lesions: failure of hyperalimentation, Intralipid and Diodoquin to reverse the intestinal lesions and generalized malabsorption syndrome. Gastroenterology 1973; 64: 692.
[19]   | Bohane TD, Cutz E, Hamilton JR, Gall DG. Acrodermatitis enteropathica, zinc, and the Paneth cell. A case report with family studies. Gastroenterology 1977; 73: 587-592.
[20]   | Singhai N, Alam S, Sherwani R, Musarrat J. Serum zinc levels in celiac disease. Indian Pediatr 2008; 45: 319-321.
[21]   | Erdem T, Ferat C, Nurdan YA, Halime E, Selcuk SM, Hamza K, Ayse SM. Vitamin and mineral deficiency in children newly diagnosed with celiac disease. Turk J Med Sci 2015; 45: 833-836.
[22]   | Tran CD, Katsikeros R, Manton N, Krebs NF, Hambridge KM,Butler RN, Davidson GP. Zinc homeostasis and gut function in children with celiac disease. Am J Clin Nutr 2011; 94: 1026-1032.
[23]   | Crofton RW, Glover SC, Ewen SW, Aggett PJ, Mowat NA, Mills CF. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983; 38: 708-712.
[24]   | Rawal P, Thapa BR, Prasad R, Prasad KK, Nain CK, Singh K. Zinc supplementation to patients with celiac disease—is it required? J Trop Pediatr 2010; 56: 391-397.
[25]   | Negi K, Kumar R, Sharma L, Datta SP, Choudhury M, Kumar P. Serum zinc, copper and iron status of children with celiac disease on three months of gluten-free diet with or without four weeks of zinc supplements: a randomized controlled trial. Trop Doct 2018; 48: 112-116.
[26]   | Freeman HJ. Iron refractory or iron resistant iron deficiency anemia in adult celiac disease resolves with a gluten-free diet. Inter J Celiac Dis 2018; 6: 26-29.
[27]   | Stenberg P, Roth B, Ohlsson B. Zinc as a modulator of transglutaminase activity—laboratory and pathophysiological aspects. J Transl Autoimmun 2021; 4: 100110.
[28]   | Roth EB, Sjoberg K, Stenberg P. Biochemical and immuno-pathological aspects of tissue transglutaminase in celiac disease. Autoimmunity 2003; 36: 221-226.
[29]   | Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747-757.
[30]   | Engstrom N, Saenz-Mendez P, Scheers J, Scheers N. Towards celiac-safe foods: decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl2 as detoxifiers. Sci Rep 2017; 7: 77.